Business
GREY WOLF ANIMAL HEALTH ANNOUNCES LAUNCH OF SILEO
GREY WOLF ANIMAL HEALTH ANNOUNCES LAUNCH OF SILEO Canada NewsWire SILEO®...
About this update from Grey Wolf Animal Health Corp
[{"type":"text","content":"\n\n\n\n GREY WOLF ANIMAL HEALTH ANNOUNCES LAUNCH OF SILEO\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n SILEO® is the first-and-only Health Canada-approved product for the alleviation of acute anxiety and fear associated with noise in dogs\n \n\n\n\n\n TORONTO\n \n\n ,\n \n\n Oct. 29, 2024\n \n\n /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) (\"Grey Wolf\" or the \"Company\"), a Canadian diversified animal health company, today announced the Canadian commercial launch of SILEO® (dexmedetomidine hydrochloride oromucosal gel) to veterinary clinics throughout Canada.  SILEO builds on Grey Wolf's portfolio dedicated to behaviour and anxiety health in companion animals.  Dogs that experience fear and anxiety in response to loud noise such as fireworks now have a new treatment option.  SILEO is available from veterinarians by prescription and can be administered at home by pet owners to help calm dogs without sedation.\n \n\n\n\n\n\n\n\n\n \"We are excited to launch SILEO in\n \n Canada\n \n , a solution for alleviating acute anxiety and fear associated with noise in dogs. We know that noise-related events can be stressful for both pets and pet owners. SILEO works by calming without sedating so pets can continue to interact with their owners,\" said Dr.\n \n Ian Sandler\n \n , Chief Veterinary Medical Officer and Founder of Grey Wolf. \"This prescription medication is another way Grey Wolf is supporting veterinarians, pets and pet owners in\n \n Canada\n \n .\"\n \n\n\n About SILEO\n \n\n\n SILEO is an oromucosal gel formulation of dexmedetomidine, a potent and selective alpha-2 adrenoceptor agonist designed to block noradrenaline release thereby reducing the physiological and behavioural manifestations of fear and anxiety. SILEO is administered oromucosally between the dog's cheek and gums, which limits the amount of dexmedetomidine available in the body and provides a calming effect without sedating.\n \n\n For more information about SILEO, please visit\n \n www.products.grey...